DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Verhamme P, Wells PS, Segers A , et al.
Dose reduction of edoxaban preserves efficacy and safety for the treatment of venous thromboembolism. An analysis of the randomised, double-blind HOKUSAI VTE trial.
Thromb Haemost 2016;
116: 747-753
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.